Thus, we find that these two molecules have advanced in different areas: Melanotan-1 (SCENESSE, Clinuvel Pharmaceuticals Ltd) is being studied in phase 2 and phase 3 clinical trials as a photoprotective drug for protection against nonmelanoma skin cancer and in other photoinduced skin diseases, such as erythropoietic protoporphyria, solar dermatitis, and polymorphic light eruption
One of the major roles of the compound is to take part in energy metabolism by transporting fatty acids into mitochondria
Carillo, M., Bertapelle, C., Scial, F., Siervo, M., Spagnuolo, G., Simeone, M., Peluso, G., & Digilio, F